Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial enzymes on tooth surfaces, primarily Glucosyltransferases (GTFs) produced by species such as Streptococcus mutans, are critical mediators of dental plaque formation and the development of dental caries (Bowen & Koo, 2011, Caries Research). These enzymes catalyze the synthesis of high-molecular-weight glucans from dietary sucrose, creating a sticky extracellular matrix that facilitates bacterial colonization and protects the microbial community from environmental stressors and antimicrobial agents (Koo et al., 2013, Nature Reviews Microbiology). By promoting the transition of the oral microbiome into a pathogenic, acid-producing biofilm, these enzymes directly contribute to the localized demineralization of tooth enamel (StatPearls, 2023, Dental Caries). Therapeutic strategies targeting these enzymes aim to disrupt biofilm architecture without necessarily killing the bacteria, thereby reducing pathogenicity while maintaining the ecological balance of the oral cavity (Jeon et al., 2011, Journal of Dental Research). Current and experimental agents include fluoride, which inhibits various metabolic enzymes, and plant-derived polyphenols that specifically target GTF activity to prevent the formation of cariogenic biofilms (Marquis, 1995, Canadian Journal of Microbiology; Gregoire et al., 2011, Critical Reviews in Food Science and Nutrition).
Inhibition of the enzymatic conversion of dietary sucrose into insoluble alpha-glucans, which prevents the formation of the sticky extracellular matrix required for bacterial adhesion and the structural integrity of dental plaque biofilms.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosyltransferase (GTF) (GTF).